Follow The Filings

OSCR Oscar Health

Oscar Health earnings company data as of 3:43 PM ET 11/13

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -0.17 GAAP 0.49 —
Rev $4.72B $5.14B Beat +8.9%

Insider trades

Open-market buys and sales by OSCR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OSCR insider trades
  • $11.9M bought by 1 insider
  • $23.4M sold by 2 insiders outside a trading plan
  • $43.4M sold by 3 insiders under 10b5-1 plans
  1. Vanessa Ames Wittman Director
    Planned sale
    $806K 25,000 shares at $32.24 18% of stake
    Traded Sep 18 Filed Sep 22
  2. Mario Schlosser Director
    Sale
    $22.8M 750,000 shares at $30.43 61% of stake
    Traded Aug 27–28 Filed Aug 31
  3. Richard Scott Blackley CFO
    Sale
    $595K 18,750 shares at $31.74 25% of stake
    Traded Aug 18 Filed Aug 20
  4. Mario Schlosser Director
    Planned sale
    $1.5M 47,500 shares at $31.24 100% of stake
    Traded Jul 1 Filed Jul 6
  5. Mario Schlosser Director
    Planned sale
    $30.2M 1,027,500 shares at $29.38
    Traded Jun 23 Filed Jun 25
  6. Richard Scott Blackley CFO
    Planned sale
    $2.8M 110,000 shares at $25.03 9% of stake
    Traded May 18 Filed May 20
  7. Richard Scott Blackley CFO
    Planned sale
    $2.3M 100,000 shares at $23.16 7.6% of stake
    Traded May 14 Filed May 18
  8. Mark T. Bertolini CEO
    Buy
    $11.9M 1,000,000 shares at $11.92 +11% to stake
    Traded Apr 6 Filed Apr 7
  9. Mario Schlosser President of Technology & CTO
    Planned sale
    $407K 23,038 shares at $17.65 6.2% of stake
    Traded Jan 8 Filed Jan 12
  10. Mario Schlosser President of Technology & CTO
    Planned sale
    $1.3M 76,962 shares at $17.01 18% of stake
    Traded Jan 6 Filed Jan 8
  11. Mario Schlosser President of Technology & CTO
    Planned sale
    $3.6M 234,861 shares at $15.28 40% of stake
    Traded Jan 2–5 Filed Jan 6
  12. Mario Schlosser President of Technology & CTO
    Planned sale
    $583K 38,835 shares at $15.00 8.1% of stake
    Traded Dec 24, 2025 Filed Dec 30, 2025

Also filed in the last 12 months, not counted as buying or selling: 33 sales to cover taxes, 16 other transactions, 14 stock grants, 11 conversions, 3 gifts, 1 share withholding for taxes, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
8-K 5.02
10-Q
8-K 2.02,9.01
SCHEDULE 13D/A —
8-K 7.01
10-Q
8-K 2.02,9.01
8-K 5.07
8-K 7.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf